This study reports the antigenic relatedness of isolates of Lelystad virus collected in the Netherlands, Germany, and the United States.
and Belgium, Spain, France, Italy, and Poland (G. Wensvoort, unpublished results). In the United States, the SIRS virus (SIRSV) was recently identified as the causal agent of the disease. 2, 3 Both the European LV and the American SIRSV have been described as small enveloped RNA viruse s 1 , 9 , 1 0 , 1 8 and LV may be a new member of the Arteriviridae. 9, 13, 18 Although a complete comparative characterization of these 2 viruses has not yet been done, the recent findings strongly indicate that they are the same.
This article reports the antigenic relationship between virus isolates from Europe and from the United States. A set of 24 field sera from pigs from the Netherlands, Germany, the United Kingdom, Belgium, France, the United States, and Canada was tested for binding with 2 LV isolates from the Netherlands, 2 from Germany, and 3 from the United States. The development of antibodies directed against the 7 isolates was also studied in a set of experimental sera obtained from pigs at various times after infection with LV or SIRSV. All regional varieties of PEARS, PRRS, or SIRS were caused by the same, albeit antigenically variable, virus.
Materials and methods
Cells. Porcine alveolar macrophages were obtained and grown as previously described. 17 Field sera. Two sera positive for LV (TH-187 and TO-36) were selected from a set of Dutch field sera previously tested. Twenty-two sera were selected from field sera sent to Lelystad for serologic diagnosis. The sera originated from Germany (BE-352, BE-392 and NI-f2), a,b the United King- Table 1. dom (PA-141615, PA-141617 and PA-142440), c Belgium Reactivity titers* from immunoperoxidase monolayer assay of porcine field sera from Europe and North America tested (PE-1960), d France (EA-2975 and EA-2985), e the United with Lelystad virus isolates from The Netherlands (NL1 and NL2), States (SL-441, SL-451, AL-RP9577, AL-P10814/33, AL-Germany (GE1 and GE2), and the United States (US1, US2, and 4994A, AL-7525, JC-MN41, JC-MN44, and JC-MN45), f,g,h US3). and Canada (RB-16, RB-19, RB-22, and RB-23). i Experimental sera. Two sets of experimental pig sera collected at various times after infection with LV (CDI-NL-2.91; Institute Pasteur I-l 102) or SIRSV (ATCC VR-2332) were prepared. Anti-LV sera originated from 4 3-mo-old specific-pathogen-free pigs from the herd at the Central Veterinary Institute. Two pigs (21 and 23) were infected intranasally with 10 5 TCID 50 of a fifth cell culture passage of LV. Two other pigs (25 and 29) were infected intranasally with a fresh suspension of the lungs of LV-infected piglets containing 10 5 TCID 50 LV. Blood samples were taken at 0, 14, 28, and 42 days postinfection (dpi).
Anti-SIRSV sera originated from 4 6-mo-old gilts with no history of SIRS. Before the experiment, the gilts were seronegative by serum neutralization tests. 8 The gilts were challenged intranasally with 10 5.1 TCID 50 SIRSV grown on cell line 2621 . 3 Blood samples were taken from gilt 2B at 0, 20, 36, and 63 dpi; from gilt 9G at 0, 30, 44, and 68 dpi; from gilt 16W at 0, 25, 40, and 64 dpi; and from gilt 16Y at 0, 36, and 64 dpi.
Viruses. Seven LV isolates were studied: NL1, NL2, GE1, GE2, US1, US2, and US3. All originated from samples sent to Lelystad for LV diagnosis and were isolated in porcine alveolar macrophages and passaged three to five times. NL1 (the original LV isolate) and NL2 were isolated in February and September 1991 from field cases of PEARS in The Netherlands. GE1 a and GE2 b were isolated in June 1991 and January 1992 from cases in Germany. US1 was isolated from a fetus born from a sow that was experimentally infected with SIRSV, 2,h US2 was isolated from a 1990 field case in Indiana, g and US3 was isolated in autumn 1991 from a field case in Illinois. f All isolates caused a cytopathic effect in macrophages, and all could be specifically immunostained with anti-LV sera.
Serology. All sera were tested in an immunoperoxidase monolayer assay (IPMA) for binding with all 7 isolates. The IPMA was performed as previously described 7 with some minor modifications. Porcine alveolar macrophages were seeded in microtiter plates as described and grown for 16 hr. Then, 50 µ1 of growth medium containing 10 3 -10 4 TCID 50 of the various isolates was added, and the macrophages were grown for 24 hr (isolates NL1, NL2, GE1, GE2, and US2), 48 hr (US1), or 72 hr (US3). The plates were then fixed and stained as described. As previously established, these incubation times resulted in 30% of the macrophages for each isolate being infected and showing good cytoplasmatic staining in IPMA.
Most sera were tested with a starting dilution of 0.5 log and were diluted further in 8 0.5 log steps, except the field sera from France, the sera AL-RP9577, RB-16, and RB-19 (which were tested with a starting dilution of 1 log), and the sera from the United Kingdom (which were tested with a starting dilution of 2 log). All sera were also tested in IPMA on uninfected macrophages. Titers were expressed as the negative log of the last dilution of the serum that still stained the cytoplasm of infected macrophages red.
Results
Field sera. None of the field sera reacted with uninfected macrophages, but all sera contained antibodies directed against one or more of the isolates (Table  1) . All European sera reacted with the European isolates and most North American sera reacted with the US isolates. Only 2 sera, SL-441 and SL-451 from the United States, reacted with all 7 isolates, although they had higher titers when tested with the 3 US isolates than with the 4 European isolates. Two sera, AL-7525 from the United States and RB-23 from Canada, re- The homologous antibody response of the set of antiassay of experimental porcine sera raised against Lelystad virus (LV) and swine infertility and respiratory syndrome virus (SIRSV) tested SIRSV sera was somewhat less rapid. Around day 20, with LV isolates from The Netherlands (NL1 and NL2), Germany the gilts had titers of approximately 2, and the titers (GE1 and GE2), and the United States (US1, US2, and US3). did not change appreciably. The response with isolate US2 was more pronounced. Only 3 of the anti-SIRSV sera had low titers with US3, and none reacted with the 4 European isolates (Table 2 ; Fig. 1, right) .
The only isolate that reacted with all anti-LV sera and with all anti-SIRSV sera was US2.
Discussion
Twenty-four pig sera originating from field cases of PEARS and PRRS in Europe and from cases of SIRS in North America were tested with the IPMA for the presence of antibodies directed against 1 or more of 7 LV isolates (4 from Europe and 3 from the United States). All sera reacted with at least 1 of these isolates, but the European sera reacted most with the European isolates. and the North American sera reacted most acted with 1 isolate only, US2. None of the Canadian sera reacted with US3. Isolates NL1 and US2 showed the most reactivity with the 24 field sera (18 out of 24 sera were positive; the mean log titers of positive sera were 2.9 and 2.7), but they clearly reacted with different subsets of sera. Isolate US3 showed the least reactivity (11 out of 24 sera were positive; the mean log titer of positive sera was 2.1).
Experimental sera. None of the anti-LV and anti-
SIRSV sera reacted with uninfected macrophages, and none of the anti-LV and anti-SIRSV sera that were collected at 0 dpi reacted with any of the isolates.
The homologous antibody response of the set of anti-LV sera with isolate NLl was rapid. At 14 dpi, all pigs had log titers of ≥ 2.5, and at 28 and 42 dpi, all pigs had titers of approximately 3.5. All anti-LV sera had equally high titers with the 3 other European isolates and had lower titers with isolates US2 and US3. Only 7 of the anti-LV sera reacted with low titers with US1 (Table 2 ; Fig. 1, left) .
with the US isolates.
Two sets of experimental sera raised against the European LV (CDI-NL-2.9 1; Institute Pasteur I-1102) or the US SIRSV (ATCC VR-2332) were also tested. The homologous response of each set of sera were higher than the heterologous responses; all anti-LV sera reacted with NL1 and all anti-SIRSV sera reacted with US1, but only 7 anti-LV sera reacted with SIRSV isolate US1 and none of the anti-SIRSV sera reacted with LV isolate NL1. Although isolates NL1 and US 1 share a common antigenic denominator, they are antigenitally different.
Antigenic variation was also detected in the other isolates, dividing the isolates into a European and a US group. Although the European isolates are antigenitally related, the US group of isolates is antigenically more diverse. Isolate US3 especially had a different antigenic reactivity with the sera tested. However, without preparing sets of sera specifically directed against the heterologous isolates, the various isolates cannot be further differentiated,
To accurately diagnose PEARS, PRRS, or SIRS, serologic and virologic tools that specifically react with a common antigen of all LV isolates are needed. Such tools can be a broadly reacting set of polyclonal antisera or monoclonal antibodies that specifically react with a common antigen. To identify this common antigen, LV, SIRSV, and additional LV isolates from various regions must be characterized and compared. Currently, LV infection cannot be reliably diagnosed without risking false-negative results, especially in areas such as the United States where LV isolates seem to vary more than do those in Europe. Development of a vaccine against PEARS, PRRS, and SIRS might be hampered by the difficulty of growing all the necessary variant viruses in a reliable and productive cell culture system and by antigenic diversity of LV in the field. d. e. f. g.
